Cervical cancer prevention advances with new immunotherapy findings, addressing disparities and improving outcomes for ...

During a live event, Deborah Wong, MD, PhD, discussed the role of PD-1 inhibitors in nasopharyngeal cancer and their ...

The Phase 1 dose escalation has been completed, and results show encouraging early signs of clinical activity in solid tumors ...

Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...

The study will be carried out in partnership with The GOG Foundation and the European Network of Gynaecological Oncological ...

A new study led by Keck Medicine of USC researchers may have uncovered an effective combination therapy for glioblastoma, a ...

"These long-term results continue to support [pembrolizumab's] use as a standard of care for patients at increased risk of ...

A new study found the drug kept head and neck cancers at bay for five years compared to 30 months with standard care ...

First-line treatment with sacituzumab govitecan plus pembrolizumab showed significant improvement in PFS vs. chemotherapy ...

A grandad diagnosed with stage 4 lung cancer–one of the deadliest—has become disease-free after being treated with an ...

Sacituzumab govitecan plus pembrolizumab improves outcomes vs chemotherapy plus pembrolizumab in patients with previously ...

A grandad with advanced lung cancer, which often leaves patients dead within four months has become free of the disease after ...